Armis Biopharma

Armis Biopharma's mission is to decrease the quantity and severity of infections that cause human and animal suffering and death through novel, targeted, antimicrobial therapies.

The company’s technology, Veriox®, is a first-of-its-kind, proprietary peracid/hydrogen peroxide based non-systemic, non-resistant antimicrobial agent. Veriox® features a novel Mechanism of Action (M of A) that reduces the likelihood of contributing to resistance against Gram+, Gram-, viral, fungal and chemical/biological warfare pathogens.

Armis is focused on efficacious, non-systemic, non-resistant antimicrobials that work as monotherapies and/or may increase the efficacy of existing systemic antibiotics.